Satellite Symposium 2019 Defining the Cancer Care Ecosystem to Determine Value

Fri May 10th 2019

Bethesda North Marriott Hotel and Conference Center

12:00 pm - 12:30 pm

Welcome/Setting the Stage

The Evidence Gap Between Regulators and HTA

Speaker

Paul Kluetz, FDA

12:30 pm - 1:15 pm

Lecture

Benchmarking Value Scales on Cancer: Compliance with the Criteria for “Accountability for Reasonableness”

Speaker

Nathan Cherny, ESMO

1:15 pm - 2:00 pm

Lecture

The Societal Role of Applied Clinical Research for Evolving Health Care Systems

Speaker

Denis Lacombe, EORTC

2:00 pm - 2:15 pm

Break

2:15 pm - 3:00 pm

Speaker Session

Evidence Needed by HTA: Data to Measure Value - Clinical Trials Data Endpoints, PROs

Speaker

Francois Maignen, UK NICE
Jennifer Malin, UnitedHealthcare

3:00 pm - 3:45 pm

Speaker Session

Future Use of RWE to Measure Values (PRO vs CON)

Speaker

Lowell Schnipper, Harvard/BID- ASCO
Christopher Booth, Queens University

3:45 pm - 4:45 pm

Roundtable Discussion

• Post-Marketing Studies • PROs • RWE

Speaker

Kim Lyerly
Christopher Booth
Nathan Cherney
Denis Lacombe
Paul Kluetz
Francois Maignen
Jennifer Malin
Lowell Schnipper